...Astellas Pharma Inc. (Tokyo:4503) acquired ophthalmic gene therapy company Quethera Ltd. (Cambridge, U.K.) for up to £85... ...cell model of neurological damage compared with empty vector. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Quethera Ltd....
...Astellas Pharma Inc. (Tokyo:4503) acquired ophthalmic gene therapy company Quethera Ltd. (Cambridge, U.K.) for up to £85... ...cell model of neurological damage compared with empty vector. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Quethera Ltd....